Free Trial
→ Trump Makes Major Crypto Announcement (From Crypto 101 Media) (Ad) Buy IOVA Stock  Free IOVA Stock Alerts

Iovance Biotherapeutics (IOVA) SEC Filings & 10K Form

Iovance Biotherapeutics logo
$2.38 +0.17 (+7.69%)
Closing price 06/10/2025 04:00 PM Eastern
Extended Trading
$2.40 +0.02 (+0.63%)
As of 05:11 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent Iovance Biotherapeutics SEC Filings

Export to Excel
DateFilerForm TypeView
06/04/2025
3:46 PM		Bellemin Jean-Marc (Reporting)
Iovance Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2025
3:47 PM		BILINSKY IGOR (Reporting)
Iovance Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2025
3:49 PM		GRAF FINCKENSTEIN FRIEDRICH (Reporting)
Iovance Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2025
3:50 PM		Iovance Biotherapeutics (Issuer)
Vogt Frederick G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2025
3:51 PM		Iovance Biotherapeutics (Issuer)
Puri Raj K. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2025
4:15 PM		Iovance Biotherapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/30/2025
4:00 PM		Iovance Biotherapeutics (Filer)
Form ARS
04/28/2025
4:00 PM		Iovance Biotherapeutics (Filer)
Form DEF 14A
04/28/2025
4:05 PM		Iovance Biotherapeutics (Filer)
Form DEFA14A
03/18/2025
7:30 PM		Iovance Biotherapeutics (Issuer)
Puri Raj K. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2025
7:05 PM		Bellemin Jean-Marc (Reporting)
Iovance Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2025
7:05 PM		BILINSKY IGOR (Reporting)
Iovance Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2025
7:06 PM		GRAF FINCKENSTEIN FRIEDRICH (Reporting)
Iovance Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2025
7:06 PM		Iovance Biotherapeutics (Issuer)
Puri Raj K. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2025
7:06 PM		Iovance Biotherapeutics (Issuer)
Vogt Frederick G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2025
7:32 PM		Iovance Biotherapeutics (Issuer)
Vogt Frederick G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2025
7:32 PM		BILINSKY IGOR (Reporting)
Iovance Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2025
7:33 PM		Bellemin Jean-Marc (Reporting)
Iovance Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2025
7:30 PM		GRAF FINCKENSTEIN FRIEDRICH (Reporting)
Iovance Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2025
7:31 PM		Iovance Biotherapeutics (Issuer)
Puri Raj K. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2025
4:15 PM		Iovance Biotherapeutics (Issuer)
Kirby Daniel Gordon (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/12/2025
4:17 PM		Iovance Biotherapeutics (Issuer)
Kirby Daniel Gordon (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2025
6:22 AM		Iovance Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/16/2025
4:59 PM		BILINSKY IGOR (Reporting)
Iovance Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/16/2025
5:00 PM		GRAF FINCKENSTEIN FRIEDRICH (Reporting)
Iovance Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/16/2025
5:01 PM		Iovance Biotherapeutics (Issuer)
Vogt Frederick G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2024
4:15 PM		Iovance Biotherapeutics (Issuer)
Puri Raj K. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2024
4:16 PM		Iovance Biotherapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
12/02/2024
4:25 PM		Iovance Biotherapeutics (Issuer)
Puri Raj K. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
11/21/2024
4:15 PM		Iovance Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
3:50 PM		Iovance Biotherapeutics (Subject)
PERCEPTIVE ADVISORS LLC (Filed by)
Form SC 13G/A
11/12/2024
6:11 PM		Iovance Biotherapeutics (Subject)
Maynard Ryan D (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/07/2024
8:03 PM		Iovance Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/07/2024
4:15 PM		Iovance Biotherapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/18/2024
7:38 AM		Iovance Biotherapeutics (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
10/16/2024
5:30 PM		BILINSKY IGOR (Reporting)
Iovance Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/16/2024
5:32 PM		GRAF FINCKENSTEIN FRIEDRICH (Reporting)
Iovance Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/16/2024
5:33 PM		Iovance Biotherapeutics (Issuer)
Vogt Frederick G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2024
6:52 PM		Bellemin Jean-Marc (Reporting)
Iovance Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2024
6:53 PM		BILINSKY IGOR (Reporting)
Iovance Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2024
6:54 PM		GRAF FINCKENSTEIN FRIEDRICH (Reporting)
Iovance Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
Why July 22nd Could Mean Big Changes for Social Security (Ad)

In a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Social Security — and his plan is set to roll out July 22. What's coming next isn't about trimming waste.

To see the full playbook and how it could impact everyone, click here.
09/05/2024
6:56 PM		Iovance Biotherapeutics (Issuer)
Vogt Frederick G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/09/2024
4:16 PM		Iovance Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2024
4:10 PM		Iovance Biotherapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/17/2024
7:00 PM		BILINSKY IGOR (Reporting)
Iovance Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2024
7:01 PM		GRAF FINCKENSTEIN FRIEDRICH (Reporting)
Iovance Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2024
7:01 PM		Iovance Biotherapeutics (Issuer)
Vogt Frederick G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2024
6:30 AM		Iovance Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/13/2024
5:00 PM		Dukes Iain D. (Reporting)
Iovance Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2024
5:00 PM		Iovance Biotherapeutics (Issuer)
Maynard Ryan D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2024
5:01 PM		Iovance Biotherapeutics (Issuer)
WEISER MICHAEL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2024
5:02 PM		Iovance Biotherapeutics (Issuer)
YARNO WENDY L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2024
5:03 PM		Countouriotis Athena (Reporting)
Iovance Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2024
4:15 PM		Iovance Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:IOVA) was last updated on 6/11/2025 by MarketBeat.com Staff
From Our Partners
Trump wipes out trillions overnight…
Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...
Porter & Company | Sponsored
Elon’s NEXT Big IPO?
Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...
Banyan Hill Publishing | Sponsored
Trump’s Exec Order #14154 could be a “Millionaire-Maker”
Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...
Paradigm Press | Sponsored
An AI run of epic proportions is only getting started
I just put together an urgent new presentation that you need to see right away. In short: I believe we are...
Timothy Sykes | Sponsored
Silicon Valley Gold Rush
A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...
Stansberry Research | Sponsored
Gold is soaring. Here’s how to get paid from it
Gold just broke through $3,300… And while the headlines shout about price targets, something even more powe...
Investors Alley | Sponsored
When This Happens, You Don’t Wait. You Act.
This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...
Crypto Swap Profits | Sponsored
Get Your Bank Account “Fed Invasion” Ready with THESE 4 Simple Steps
Starting as soon as a few months from now, the United States government will make a sweeping change to bank ac...
Weiss Ratings | Sponsored